Selank comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-01-17. Numbers and descriptions here follow the published literature rather than marketing material.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C33H57N11O9 | Free peptide form |
| Molecular mass | About 751.9 Da | Calculated average mass |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Single-letter form TKPRPGP |
| Structural basis | Tuftsin analogue | Extended version of a natural tetrapeptide |
| Development origin | Russian Academy of Sciences | Work carried out from the 1980s onward |
Naming conventions place Selank in the same research family as Semax, another Russian-developed peptide investigated for cognitive effects. The two compounds share a lineage but differ in sequence and in the biological systems proposed as their targets. Semax descends from ACTH fragments, whereas Selank descends from tuftsin. Publications sometimes identify Selank by its full peptide sequence or by laboratory codes rather than one uniform trade name. Because replication outside Russia is limited, reports on its properties are best read alongside the study design and the purity of the material tested.
Selank is a synthetic heptapeptide developed in Russia during the 1990s. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences designed it as a stabilized analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The compound has been studied primarily for its reported anxiolytic and nootropic effects. It remains largely unknown in Western pharmacology and is not approved as a medicine by major regulators such as the FDA or the EMA.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.
In Germany, democratic socialism became a prominent movement at the end of the 19th century, when the Eisenach's Social Democratic Workers' Party of Germany merged with Lassalle's General German Workers' Association in 1875 to form the Social Democratic Party of Germany. Reformism arose as an alternative to revolution, with leading social democrat Eduard Bernstein proposing the concept of evolutionary socialism. Revolutionary socialists, encompassing multiple social and political movements that may define revolution differently from one another, quickly targeted the nascent ideology of reformism and Rosa Luxemburg condemned Bernstein's Evolutionary Socialism in her 1900 essay titled Social Reform or Revolution? The Social Democratic Party of Germany became the largest and most powerful socialist party in Europe despite being an illegal organisation under Otto von Bismarck's Anti-Socialist Laws until they were repealed in 1890. In the 1893 German federal election, the party gained about 1,787,000 votes, a quarter of the total votes cast according to Engels. In 1895, the year of his death, Engels highlighted The Communist Manifesto's emphasis on winning as a first step the "battle of democracy."
== Cell differentiation == Epidermal stem cells reside in the lower part of the epidermis (stratum basale) and are attached to the basement membrane through hemidesmosomes. Epidermal stem cells divide in a random manner yielding either more stem cells or transit amplifying cells. Some of the transit amplifying cells continue to proliferate then commit to differentiate and migrate towards the surface of the epidermis. Those stem cells and their differentiated progeny are organized into columns named epidermal proliferation units. During this differentiation process, keratinocytes permanently withdraw from the cell cycle, initiate expression of epidermal differentiation markers, and move suprabasally as they become part of the stratum spinosum, stratum granulosum, and eventually corneocytes in the stratum corneum. Corneocytes are keratinocytes that have completed their differentiation program and have lost their nucleus and cytoplasmic organelles. Corneocytes will eventually be shed off through desquamation as new ones come in. At each stage of differentiation, keratinocytes express specific keratins, such as keratin 1, keratin 5, keratin 10, and keratin 14, but also other markers such as involucrin, loricrin, transglutaminase, filaggrin, and caspase 14. In humans, it is estimated that keratinocytes turn over from stem cells to desquamation every 40–56 days, whereas in mice the estimated turnover time is 8–10 days. Factors promoting keratinocyte differentiation are:
The Welsh Romance Peredur son of Efrawg is based on Chrétien or derived from a common original, but it contains several prominent deviations and lacks a Grail. The character of the Fisher King appears (though he is not called such) and presents Peredur with a severed head on a platter. Peredur later learns that he was related to that king, and that the severed head was that of his cousin, whose death he must avenge by defeating the Nine Witches.
4 March COVID-19 in the UK: Lockdown Files: The latest leaked WhatsApp messages published by the Daily Telegraph indicate, according to BBC News who have not seen or verified the messages, that Matt Hancock and his staff deliberated over whether or not he had broken COVID-19 regulations after pictures of him kissing his aide, Gina Coladangelo, were published by The Sun newspaper. Other messages also show Hancock criticising the Eat Out to Help Out scheme for "causing problems" in areas where there were a high number of COVID-19 cases. Typhoon jets are scrambled from RAF Coningsby in Lincolnshire to help escort a civilian plane en route from Iceland to Kenya following a loss of communication caused by an equipment malfunction. A sonic boom is heard over parts of England after the jets are allowed to fly at supersonic speed. 5 March Train fares in England and Wales are increased by up to 5.9%, representing the largest increase in more than a decade. COVID-19 in the UK: Lockdown Files: News outlets including BBC News, Sky News and The Independent — who have not verified the messages — report that further WhatsApp messages published by The Telegraph appear to show discussions about how and when the government should reveal details of the Kent variant in order to ensure people would comply with COVID-19 regulations. The news outlets also say Hancock appears to suggest they should "frighten the pants off everyone", while in another conversation, head of the civil service Simon Case suggests the "fear/guilt factor" is an important element of the government's messaging.
Sources: en.wikipedia.org
Thanks to the protective function of radioprotectors, the dose of radiation used to treat malignant tumors (cancer) can be increased, thereby increasing the effectiveness of the therapy. There are also radiosensitizers, which increase the sensitivity of malignant tumor cells to ionizing radiation. As early as 1921, the German radiologist Hermann Holthusen (1886-1971) described that oxygen increases the sensitivity of cells.
calculates the abundance of carbon-13 relative to carbon-12 in all methane molecules. For the random distribution (i.e. probability distribution), the probability of choosing a carbon-13 atom over a carbon-12 atom is
=== Carrier state === Some people who have had an infectious disease such as tuberculosis never completely recover and continue to carry the infection, whilst not suffering the disease themselves. They may then move back into the infectious compartment and suffer symptoms (as in tuberculosis) or they may continue to infect others in their carrier state, while not suffering symptoms. The most famous example of this is probably Mary Mallon, who infected 22 people with typhoid fever. The carrier compartment is labelled C.
19 September — Commuters are stranded for three hours on a Metlink Waikanae train after an overhead power cable was detached at 7:40 am. 20 September – Thousands gather in various centres across New Zealand including Christchurch to oppose the Government's pay equity changes. 22 September – A partial solar eclipse occurs above mainland New Zealand, starting at sunrise and reaching maximum around 7 am. Views from most of the North Island are blocked by clouds. 23 September – Hakyung Lee is convicted by the Auckland High Court of murdering her two children in 2022. 24 September – Anna Breman is designated as the first female Governor of the Reserve Bank of New Zealand. 25 September — The New Zealand Government reopens applications for oil and gas exploration throughout the country. 26 September The Sealord Group proposes reducing its Nelson wetfish and by-products factories and fresh fish trawler operations from full-time to seasonal operations; potentially affecting 59 roles. Esarona David Lologa is convicted by a jury of the High Court in Wellington of carrying out the Loafers Lodge fire in 2023. Foreign Minister Winston Peters confirms during the 80th session of the United Nations General Assembly that New Zealand will not recognise Palestinian statehood. 27 September – The Presbyterian Church of Aotearoa New Zealand issues its first apology to survivors of historical abuse in care in Dunedin. 28 September — Four measles cases (three historical and one linked to international travel) are reported in the Northland Region.
In an incomplete elution, part of the analytes remain in the sorbent because the eluent used does not have a strong enough affinity. Many of the adsorbents/materials are the same as in chromatographic methods, but SPE is distinctive, with aims separate from chromatography, and so has a unique niche in modern chemical science.
Sources: en.wikipedia.org
It is a seven-amino-acid peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, produced by chemical synthesis rather than extracted from biological tissue. Its design is based on tuftsin, a natural immunomodulatory tetrapeptide. The C-terminal Pro-Gly-Pro segment is a common stabilising motif in short regulatory peptides.
The core four residues correspond to tuftsin, which occurs naturally as part of immunoglobulin G. The full seven-residue sequence, however, is not a known endogenous peptide. It is a laboratory-designed analogue intended to combine tuftsin-like activity with greater resistance to breakdown.
No single receptor has been confirmed as the primary target. Reports describe involvement of the GABAergic system, interference with enkephalin degradation, and shifts in neurotrophic factor expression. Because these observations come from different models and assays, they have not yet been integrated into one accepted mechanism.
Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.